MR angiography for detection of pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia

American Journal of Roentgenology

Volumn 190, Issue 4, 2008, Pages 892-901

  Schneider, Guenther ^a   Uder, Michael ^b   Koehler, Michael ^c   Kirchin, Miles A ^d   Massmann, Alexander ^a   Buecker, Arno ^a   Geisthoff, Urban ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Bracco Imaging SpA   (Italy)

Author keywords

Contrast enhanced MR angiography; Embolization therapy; Hereditary hemorrhagic telangiectasia; Lung; Pulmonary angiography; Pulmonary arteriovenous malformations; Screening

Indexed keywords

GADOBENATE DIMEGLUMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CHILD; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; RENDU OSLER WEBER DISEASE; SCREENING TEST; STUDENT T TEST; ARTERIOVENOUS MALFORMATION; COMPUTER ASSISTED DIAGNOSIS; CONGENITAL MALFORMATION; MIDDLE AGED; PULMONARY ARTERY; PULMONARY VEIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS MALFORMATIONS; CHILD; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PULMONARY ARTERY; PULMONARY VEINS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 42449142638     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2966     Document Type: Article

References (62)

1. Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J 2003; 79:18-24
2. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med 1999; 245:31-39
3. Bideau A, Plauchu H, Brunet G, Robert J. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Popul 1989; 44:3-22
4. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002; 19:140-148
5. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333:918-924
6. Memeo M, Stabile Ianora AA, Scardapane A, Buonamico P, Sabba C, Angelelli G. Hepatic involvement in hereditary hemorrhagic telangiectasia: CT findings. Abdom Imaging 2004; 29:211-220
7. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992; 29:527-530
8. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32:291-297
9. Ference BA, Shannon TM, White RI Jr, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994; 106:1387-1390
10. Shovlin CL, Hughes JM, Tuddenham EG, et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994; 6:205-209
11. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995; 99:519-524
12. Kjeldsen AD, Oxhoj H, Andersen PE, Elle B, Jacobsen JP, Vase P. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999; 116:432-439
13. Sluiter-Eringa H, Orie NG, Sluiter HJ. Pulmonary arteriovenous fistula: diagnosis and prognosis in noncompliant patients. Am Rev Respir Dis 1969; 100:177-188
14. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 1985; 218:105-109
15. Khurshid I, Downie GH. Pulmonary arteriovenous malformation. Postgrad Med J 2002; 78:191-197
16. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54:714-729
17. Bosher LH Jr, Blake DA, Byrd BR. An analysis of the pathologic anatomy of pulmonary arteriovenous aneurysms with particular reference to the applicability of local excision. Surgery 1959; 45:91-104
18. Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JM. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. Q J Med 1995; 88:879-887
19. Post MC, Letteboer TG, Mager JJ, Plokker TH, Kelder JC, Westermann CJ. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005; 128:2485-2489
20. Roman G, Fisher M, Perl DP, Poser CM. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol 1978; 4:130-144
21. Hewes RC, Auster M, White RI Jr. Cerebral embolism: first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 1985; 8:151-155
22. Moussouttas M, Fayad P, Rosenblatt M, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000; 55:959-964
23. Kjeldsen AD, Oxhoj H, Andersen PE, Green A, Vase P. Prevalence of pulmonary arteriovenous malformations (pulmonary AVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT). J Intern Med 2000; 248:255-262
24. Folz BJ, Wollstein AC, Alfke H, et al. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol 2004; 261:509-516
25. Chang RK, Alejos JC, Atkinson D, et al. Bubble contrast echocardiography in detecting pulmonary arteriovenous shunting in children with univentricular heart after cavopulmonary anastomosis. J Am Coll Cardiol 1999; 33:2052-2058
26. Nanthakumar K, Graham AT, Robinson TI, et al. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 2001; 141:243-246
27. Jassal DS, Qureshi A, Neilan TG, Nomura C, Wittram C, King ME. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: an echocardiographic perspective. J Am Soc Echocardiogr 2006; 19:229.e5-229.e7
28. Whyte MK, Peters AM, Hughes JM, et al. Quantification of right to left shunt at rest and during exercise in patients with pulmonary arteriovenous malformations. Thorax 1992; 47:790-796
29. Thompson RD, Jackson J, Peters AM, Dore CJ, Hughes JM. Sensitivity and specificity of radio-isotope right-left shunt measurements and pulse oximetry for the early detection of pulmonary arteriovenous malformations. Chest 1999; 115:109-113
30. Andrivet P, Lofaso F, Carette MF, Allegrini J, Adnot S. Haemodynamics and gas exchange before and after coil embolization of pulmonary arteriovenous malformations. Eur Respir J 1995; 8:1228-1230
31. Genovesi MG, Tierney DF, Taplin GV, Eisenberg H. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels: limitation of conventional techniques. Am Rev Respir Dis 1976; 114:59-65
32. Rankin S, Faling LJ, Pugatch RD. CT diagnosis of pulmonary arteriovenous malformations. J Comput Assist Tomogr 1982; 6:746-749
33. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992; 182:809-816
34. Remy J, Remy-Jardin M, Giraud F, Wattinne L. Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology 1994; 191:657-664
35. Lawler LP, Fishman EK. Multi-detector row CT of thoracic disease with emphasis on 3D volume rendering and CT angiography. RadioGraphics 2001; 21:1257-1273
36. Remy-Jardin M, Dumont P, Brillet PY, Dupuis P, Duhamel A, Remy J. Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up. Radiology 2006; 239:576-585
37. De Cillis E, Burdi N, Bortone AS, et al. Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic telangiectasia. Curr Pharm Des 2006; 12:1243-1248
38. Rotondo A, Scialpi M, Scapati C. Pulmonary arteriovenous malformation: evaluation by MR angiography. AJR 1997; 168:847-849
39. Khalil A, Farres MT, Mangiapan G, Tassart M, Bigot JM, Carette MF. Pulmonary arteriovenous malformations. Chest 2000; 117:1399-1403
40. Maki DD, Siegelman ES, Roberts DA, Baum RA, Gefter WB. Pulmonary arteriovenous malformations: three-dimensional gadolinium-enhanced MR angiography - initial experience. Radiology 2001; 219:243-246
41. Goyen M, Ruehm SG, Jagenburg A, Barkhausen J, Kroger K, Debatin JF. Pulmonary arteriovenous malformation: characterization with time-resolved ultrafast 3D MR angiography. J Magn Reson Imaging 2001; 13:458-460
42. Ohno Y, Hatabu H, Takenaka D, Adachi S, Hirota S, Sugimura K. Contrast-enhanced MR perfusion imaging and MR angiography: utility for management of pulmonary arteriovenous malformations for embolotherapy. Eur J Radiol 2002; 41:136-146
43. Puvaneswary M. Three-dimensional gadolinium-enhanced magnetic resonance angiography of pulmonary arteriovenous malformation. Australas Radiol 2002; 46:189-193
44. Pedersen MR, Fisher MT, van Beek EJ. MR imaging of the pulmonary vasculature: an update. Eur Radiol 2006; 16:1374-1386
45. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91:66-67
46. Gershon AS, Faughnan ME, Chon KS, et al. Transcatheter embolotherapy of maternal pulmonary arteriovenous malformations during pregnancy. Chest 2001; 119:470-477
47. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7:787-804
48. Andersen PE, Kjeldsen AD, Oxhoj H, Vase P, White RI Jr. Embolotherapy for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Acta Radiol 1998; 39:723-726
49. Esplin MS, Varner MW. Progression of pulmonary arteriovenous malformation during pregnancy: case report and review of the literature. Obstet Gynecol Surv 1997; 52:248-253
50. Symbas PN, Goldman M, Erbesfeld MH, Vlasis SE. Pulmonary arteriovenous fistula, pulmonary artery aneurysm, and other vascular changes of the lung from penetrating trauma. Ann Surg 1980; 191:336-340
51. Moore JW, Kirby WC, Madden WA, Gaither NS. Development of pulmonary arteriovenous malformations after modified Fontan operations. J Thorac Cardiovasc Surg 1989; 98:1045-1050
52. Kamei K, Kusumoto K, Suzuki T. Pulmonary amyloidosis with pulmonary arteriovenous fistula. Chest 1989; 96:1435-1436
53. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006; 41:213-221; erratum in Invest Radiol 2006; 41:859
54. Prokop M, Schneider G, Vanzulli A, et al. Contrast-enhanced MR angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 2005; 234:399-408
55. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 2005; 235:791-797
56. Pediconi F, Catalano C, Occhiato R, et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 2005; 237:45-56
57. Maravilla KR, Maldjian JA, Schmalfuss IM, et al. Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents. Radiology 2006; 240:389-400
58. Hartnell GG, Allison DJ. Coil embolization in the treatment of pulmonary arteriovenous malformations. J Thorac Imaging 1989; 4:81-85
59. Dutton JA, Jackson JE, Hughes JM, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. AJR 1995; 165:1119-1125
60. Gupta P, Mordin C, Curtis J, Hughes JM, Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. AJR 2002; 179:347-355
61. Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI Jr. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006; 17:35-44
62. Anabtawi IN, Ellison RG, Ellison LT. Pulmonary arteriovenous aneurysms and fistulas: anatomical variations, embryology, and classification. Ann Thorac Surg 1965; 122:277-285